跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Piptavid - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Piptavid
Approved
STANDARD
Piptavid
Zhuhai United Laboratories (Zhongshan) Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ae35df26ed8b69f1
Company
Zhuhai United Laboratories (Zhongshan) Co., Ltd.
Type
Standard
Approval Details
Approval Id
ae35df26ed8b69f1
Drug Approval Philippines Name
Piptavid
Product Name
Piptavid
Registration Number
DRP-11079
Brand Name
Piptavid
Generic Name
Piperacillin (as sodium) + Tazobactam (As sodium)
Dosage Form
Powder For Injection (IV)
Dosage Strength
4g/500mg
Manufacturer
Zhuhai United Laboratories (Zhongshan) Co., Ltd.
Trader
Hovid Bhd.
Importer
Hovid Inc.
Distributor
Hovid Inc.
Issuance Date
26 January 2022
Expiry Date
26 January 2027
Pharmacologic Category
Antibacterial (Piperacillin/Beta-lactamase inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ae35df26ed8b69f1
Type
Standard
Back to Philippines FDA Approvals